Syndax Pharmaceuticals Inc Business Operations Contracts & Agreements
11 Contracts & Agreements
- Collaboration Agreements (5 contracts)
- Indemnification Agreements (2)
- Sales Agreements (1)
- Settlement Agreements (1)
- Termination Agreements (2)
- Sales Agreement, dated May 26, 2023 (Filed With SEC on May 26, 2023)
- MUTUAL RELEASE AND SETTLEMENT AGREEMENT (Filed With SEC on August 8, 2022)
- Collaboration and License Agreement by and between the Company and Incyte Corporation, dated as of September 24, 2021 (Filed With SEC on November 15, 2021)
- AMENDMENT NO. 1 TO CLINICAL TRIAL COLLABORATION AND SUPPLY AGREEMENT (FOR NON-SMALL CELL LUNG CANCER STUDY WITH EXPANSION COHORTS INNON-SMALL CELL LUNG CANCER, MELANOMA, AND... (Filed With SEC on August 10, 2017)
- CLINICAL TRIAL COLLABORATION AND SUPPLY AGREEMENT (Filed With SEC on January 11, 2016)
- COMBINATION STUDY COLLABORATION AGREEMENT BETWEEN GENENTECH, INC. AND SYNDAX PHARMACEUTICALS, INC. TABLE OF CONTENTS (Filed With SEC on January 4, 2016)
- CLINICAL TRIAL COLLABORATION AND SUPPLY AGREEMENT (FOR NON-SMALL CELL LUNG CANCER STUDY WITH EXPANSION COHORTS IN NON-SMALL CELL LUNG CANCER AND MELANOMA) (Filed With SEC on January 4, 2016)
- INDEMNIFICATION AGREEMENT (Filed With SEC on January 4, 2016)
- TABLE OF CONTENTS Section 1 Definitions Section 2 Grant and Reservation of Rights Section 3 Economic Consideration Section 4 Sublicensing Section 5 U.S. Government Rights Section... (Filed With SEC on May 16, 2014)
- TABLE OF CONTENTS Section 1 Definitions Section 2 Grant and Reservation of Rights Section 3 Economic Consideration Section 4 Sublicensing Section 5 U.S. Government Rights Section... (Filed With SEC on March 27, 2014)
- INDEMNIFICATION AGREEMENT (Filed With SEC on March 27, 2014)
